BC1618
CAS: 2222094-18-8
Ref. 3D-XND09418
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Product Information
BC1618 is a peptide that activates the GABA(A) receptor. It has been shown to be a high-potency activator of the GABA(A) receptor, with an EC50 of 2.5 nM in recombinant cell lines. BC1618 has also been shown to inhibit ligand-gated ion channels and produce long-lasting changes in cell membrane potentials. In addition, BC1618 is a potent inhibitor of the voltage-dependent calcium channel (VDCC) current with an IC50 of 100 nM.
The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a drug used for tuberculosis treatment that inhibits bacterial growth by binding to DNA dependent RNA polymerase and prevents transcription and replication. The high frequency of human activity has been shown using patch clamp technique on human erythrocytes. This active form is metabolized through a number of metabolic transformations, including hydrolysis
Chemical properties
Technical inquiry about: 3D-XND09418 BC1618
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
